Advanced prostatic carcinoma Early versus late endocrine therapy landmark observations Huggins Hodges androgen deprivation mainstay treatment advanced-stage prostate cancer studies enhanced survival hormonal therapy view disfavor result observations first second VACURG studies proliferation experimental clinical data early androgen deprivation reanalysis VACURG data survival advantage patients stage disease high-grade tumors androgen-ablative therapy time diagnosis risk-benefit analysis review supportive early hormonal therapy long-term survival patients metastatic prostate cancer development novel treatment strategies effective androgen-resistant tumor cells use concert early androgen deprivation 